Cross Country Healthcare, Inc. (NASDAQ:CCRN - Get Free Report) has earned a consensus recommendation of "Hold" from the six brokerages that are currently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $19.20.
Several analysts recently issued reports on CCRN shares. Truist Financial reduced their price target on Cross Country Healthcare from $17.00 to $15.00 and set a "hold" rating for the company in a research note on Monday, October 21st. Barrington Research reduced their price target on Cross Country Healthcare from $21.00 to $19.00 and set an "outperform" rating for the company in a research note on Thursday, August 8th.
Check Out Our Latest Research Report on Cross Country Healthcare
Cross Country Healthcare Stock Up 0.3 %
Shares of NASDAQ CCRN traded up $0.03 during midday trading on Tuesday, hitting $11.84. 324,482 shares of the company's stock were exchanged, compared to its average volume of 525,905. Cross Country Healthcare has a 12 month low of $11.46 and a 12 month high of $23.64. The company's 50 day moving average price is $13.52 and its 200 day moving average price is $14.67. The firm has a market capitalization of $411.72 million, a PE ratio of 9.08, a price-to-earnings-growth ratio of 2.37 and a beta of 0.63.
Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last released its quarterly earnings results on Wednesday, July 31st. The business services provider reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.14 by ($0.04). The firm had revenue of $339.77 million during the quarter, compared to the consensus estimate of $334.75 million. Cross Country Healthcare had a net margin of 0.54% and a return on equity of 7.29%. The business's revenue for the quarter was down 37.2% compared to the same quarter last year. During the same quarter last year, the firm earned $0.69 earnings per share. On average, equities research analysts anticipate that Cross Country Healthcare will post 0.52 EPS for the current year.
Insider Buying and Selling at Cross Country Healthcare
In other Cross Country Healthcare news, insider Karen Mote sold 13,829 shares of Cross Country Healthcare stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $17.08, for a total value of $236,199.32. Following the completion of the transaction, the insider now directly owns 24,696 shares of the company's stock, valued at $421,807.68. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, VP Cynthia Ann Grieco sold 1,945 shares of the business's stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $17.21, for a total transaction of $33,473.45. Following the completion of the transaction, the vice president now owns 7,605 shares of the company's stock, valued at approximately $130,882.05. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Karen Mote sold 13,829 shares of the business's stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $17.08, for a total value of $236,199.32. Following the transaction, the insider now directly owns 24,696 shares of the company's stock, valued at $421,807.68. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 4.90% of the company's stock.
Hedge Funds Weigh In On Cross Country Healthcare
A number of institutional investors have recently modified their holdings of the business. SummerHaven Investment Management LLC grew its position in Cross Country Healthcare by 3.8% during the 2nd quarter. SummerHaven Investment Management LLC now owns 28,376 shares of the business services provider's stock worth $393,000 after acquiring an additional 1,032 shares during the last quarter. Raymond James & Associates grew its position in Cross Country Healthcare by 0.7% during the 2nd quarter. Raymond James & Associates now owns 165,324 shares of the business services provider's stock worth $2,288,000 after acquiring an additional 1,155 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in Cross Country Healthcare by 9.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 16,639 shares of the business services provider's stock worth $312,000 after acquiring an additional 1,450 shares during the last quarter. GAMMA Investing LLC grew its position in Cross Country Healthcare by 32.8% during the 3rd quarter. GAMMA Investing LLC now owns 7,543 shares of the business services provider's stock worth $101,000 after acquiring an additional 1,865 shares during the last quarter. Finally, Versor Investments LP grew its position in Cross Country Healthcare by 20.4% during the 2nd quarter. Versor Investments LP now owns 12,400 shares of the business services provider's stock worth $172,000 after acquiring an additional 2,100 shares during the last quarter. Institutional investors and hedge funds own 96.03% of the company's stock.
Cross Country Healthcare Company Profile
(
Get Free ReportCross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Recommended Stories
Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.